{{-- --}}
{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf

A survey to assess the usage pattern of Escitalopram in the management of depression in India

Survey Questionnaire Form
Doctor’s details
@if (isset(session()->get('doctor')['vCentralCode']))
@else
@endif

Questionnaire

  1. How many patients of depression do you see in a month? *
  2. In your clinical practice depression in commonly found in? *
  3. In your clinical experience, depression is more commonly diagnosed in which age group of patients ? *
  4. In your clinical practice what is / are the most common cause/s of depression? *
  5. In your clinical practice which scale do you prefer for screening the patient for depression? *
  6. In your clinical practice which of the following guidelines do you primarily use for the management of major depressive disorder? *
  7. In your clinical practice what is your preferred first choice of antidepressant in treatment naïve depression patients? *
  8. Which is your preferred SSRI as first line antidepressant for treatment of depression? *
  9. As per your clinical experience, which factors are critical for choosing first-line treatment option in the management of depression? *
  10. Have you prescribed escitalopram for managing depression in the past 1 month? *
  11. What percentage of your depressed patients currently take escitalopram? *
  12. What is the typical starting dose of Escitalopram you prescribe for adult patients with depression? *
  13. How often do you adjust the dosage of Escitalopram during treatment? *
  14. How do you assess disease progression and treatment response in patients of depression? *
  15. In your experience, how long does it usually take for patients to experience symptom improvement with Escitalopram? *
  16. What factors influence your decision to prescribe Escitalopram over other antidepressants? *
  17. How often do you schedule follow-up appointments with patients after initiating Escitalopram treatment? *
  18. Do you recommend lifestyle modifications in conjunction with Escitalopram treatment? *
  19. What strategies do you use to enhance patient adherence to Escitalopram therapy? *
  20. In your clinical practice do you prescribe Escitalopram in depressed patients with comorbidities ? (e.g., anxiety disorders, Cardiovascular disorder etc.) *
  21. How often do you prescribe the fixed dose combination of escitalopram and clonazepam for the treatment of depression? *
  22. Based on your clinical experience, knowledge and practice, what are the potential reasons for choosing escitalopram? *
  23. In your experience, how effective is escitalopram in reducing depression? *
  24. What factors do you find most commonly contribute to medication non-adherence in major depressive disorder patients? *
  25. What percentage of your patients report satisfactory compliance with escitalopram treatment? *
  26. Mention some initial instructions/advice you give to your patients before initiating escitalopram for the treatment of Major depressive disorder? *
  27. What is your opinion on long-term Escitalopram use for maintenance therapy in depression? *
  28. What is the most significant challenge you face in managing depression patients? *
  29. In your opinion, what advantage does escitalopram offer over existing therapies for major depressive disorder? *
  30. What are your thoughts on the efficacy and overall tolerability of escitalopram compared to other antidepressant in the management of major depressive disorder? *